Abstract: The present disclosure discloses a method of sharing information with digital television (“DTV”) terminals and terminal and system for the same, the method comprising: establishing a communication connection between a DTV terminal and a mobile terminal; sending from the DTV terminal to the mobile terminal the DTV terminal's data receiving port information; and sending one or more multimedia files from the mobile terminal to the DTV terminal in accordance with the DTV terminal's data receiving port information. The present disclosure can accomplish information sharing between mobile terminals and DTV terminals, thereby realizing easy and convenient browsing or playback of multimedia files, taking advantage of DTVs' superior multimedia playback effect and avoiding the inconvenience brought about by wired connections.

Abstract: Data indicating a plurality of informational items is received at a processor. The data further comprises at least one useful informational item. Also received at the processor is data indicating a plurality of questions, including at least one unanswered question. The processor analyzes the data to determine a number of unanswered questions and a number of useful informational items. The processor generates a visualization comparing the number useful informational items to the number of unanswered questions. The visualization is displayed on a display.

Abstract: According to one embodiment, an active material is provided. The active material includes orthorhombic system oxide represented by the following formula: LixM1M22O6. In this formula, 0?x?5, M1 is at least one selected from the group consisting of Fe and Mn, and M2 is at least one selected from the group consisting of Nb, Ta and V.

Abstract: Among other aspects, provided herein are multi-armed polymer conjugates comprising an alkanoate-linker, compositions comprising such conjugates, and related methods of making and administering the same. Methods of treatment employing such conjugates and related uses are also provided. The conjugates are prepared with high drug loading efficiencies.

Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water-soluble oligomer.

Abstract: The invention relates to (among other things) oligomer-PTK inhibitor conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over PTK inhibitor compounds lacking a water-soluble, non-peptidic oligomer.

Abstract: A method, system and non-transitory computer-readable medium for predicting customer attrition are provided. The method can include executing code to load historical data relating to a customer into a database to create a customer history summary file. The method can include executing code to load daily data relating to the customer into a scoring engine. The method can include programmatically processing, via the scoring engine, at least one of the historical data and the daily data to generate an attrition score. The attrition score can indicate a predictive signal of attrition of the customer.

Abstract: Stilbene analogs and pharmaceutical compositions that are useful for the treatment of various cancers, including without limitation, colorectal cancer (CRC) and breast cancer are disclosed. Such stilbene analogs include, for example, compounds of the following formula: wherein Ra, Rb, R4, R6, R7, R9 and R10 are all H; R2 and R3 are independently H, halo, amino, alkylamino, dialkylamino, N-oxides of dialkylamino, arylalkylamino, trialkylammonium, mercapto, alkylthio, alkanoyl, nitro, nitrosyl, cyano, alkoxy, alkenyloxy, aryl, heteroaryl, sulfonyl, sulfonamide, CONR11R12, NR11CO(R13), NR11COO(R13) or NR11CONR12R13; R11, R12 and R13, are independently, H, alkyl, aryl, heteroaryl or a fluorine; R8 is NRCRdZ wherein Rc is H, alkyl, alkoxy, aryl or heteroaryl, Rd is an alkyl group, Z is a an unshared pair of electrons, H, alkyl or oxygen; and R1 and R5 are halogen.

Abstract: Hybridoma cell line 10G4 and monoclonal antibody against total aflatoxins produced by the hybridoma cell line 10G4. The hybridoma cell line 10G4 is used to produce the monoclonal antibody that binds specifically total aflatoxin B1, B2, G1 and G2. The titer of the mouse ascites antibody produced by the 10G4 treated mouse is determined through non-competitive enzyme-linked immunosorbent assay and the titer can reach up to 5.12×105. The monoclonal antibody against total aflatoxin B1, B2, G1 and G2 are used for better identification of aflatoxin B1, B2, G1 and G2 with good consistency. The 50% inhibitory concentrations (IC50) of the antibody against aflatoxin B1, B2, G1 and G2 are 2.09 ng/mL, 2.23 ng/mL, 2.19 ng/mL and 3.21 ng/mL respectively. The range of cross reaction rate for aflatoxin B1, B2, G1 and G2 is about 65.2%-100%. The antibody is used for quantitative measurement of total aflatoxin B1, B2, G1 and G2.

Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the small molecule drug not attached to the water-soluble oligomer.

Abstract: Among other aspects, provided herein are multi-armed polymer conjugates comprising an alkanoate-linker, compositions comprising such conjugates, and related methods of making and administering the same. Methods of treatment employing such conjugates and related uses are also provided. The conjugates are prepared with high drug loading efficiencies.

Abstract: The present disclosure relates to a method and system dynamic modification of desktop layout and a computer storage medium thereof. The method includes: obtaining desktop elements; placing the desktop elements on the desktop area; receiving requests for modifying the desktop elements; and modifying the desktop elements according to the requests for modification. The method and system for dynamic modification of desktop layout and computer storage medium thereof could modify desktop elements according to requests for modifying desktop elements; the desktop elements could be elastically modified to meet different demands.

Abstract: Provided herein is a straightforward and efficient method for covalently attaching a polyethylene glycol polymer to a taxane. The method involves, among other things, a step of reacting a taxame with a polyethylene glycol polymer comprising a functional group reactive with a functional group within said taxane in the presence of a coupling reagent and DPTS. The result of the reacting step is the formation of a polyethylene glycol-taxane conjugate.

Abstract: The invention relates to (among other things) oligomer-dantrolene conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered compounds.

Abstract: According to one embodiment, there is provided an active material including a titanium oxide compound having a monoclinic titanium dioxide crystal structure and satisfying the equation (I). S1/(S2+S3)?1.9??(I). In the above equation, S1 is the peak area of a peak existing in a wavelength range from 1430 cm?1 to 1460 cm?1, S2 is the peak area of a peak existing in a wavelength range from 1470 cm?1 to 1500 cm?1, and S3 is the peak area of a peak existing in a wavelength range from 1520 cm?1 to 1560 cm?1, in the infrared diffusion reflective spectrum of the active material after pyridine is absorbed and then released.

Abstract: The invention provides protease inhibitors that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the protease inhibitors not attached to the water-soluble oligomer.

Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water soluble oligomer.

Abstract: Provided herein is a straightforward and efficient method for covalently attaching a polyethylene glycol polymer to a taxane. The method involves, among other things, a step of reacting a taxame with a polyethylene glycol polymer comprising a functional group reactive with a functional group within said taxane in the presence of a coupling reagent and DPTS. The result of the reacting step is the formation of a polyethylene glycol-taxane conjugate.

Abstract: The invention relates to (among other things) oligomer-dantrolene conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered compounds.

Abstract: The molecular mechanism underlying degenerative joint disease, also known as osteoarthritis (OA), is not fully understood. Disruption of mitogen inducible gene 6 (Mig-6) in mice by homologous recombination (KO mice) led to early onset OA as revealed by simultaneous enlargement and deformity of multiple joints, degradation of articular cartilage and the development of bony outgrowths or osteophytes within the joint space. The latter appeared to be derived from proliferation of mesenchymal progenitor cells followed by differentiation into chondrocytes. Because of the striking similarity to human OA, Mig-6 KO mice arc a useful animal model for studying the mechanism of this disease and for testing new drugs or therapies for treating OA. These KO mice also developed epithelial hyperplasia, adenoma, and adenocarcinoma in organs such as lung, gallbladder, and bile duct. Mig-6 is therefore a tumor suppressor gene and is a candidate gene for the frequent Ip36 genetic alterations found in lung cancer.